TP53 and neoplasm: The inclusion of other covariates to the model that were associated with survival in the univariable analysis (age, TNM stage, ER status in addition to HI and p53 mutation status) yielded a borderline significant association for both HI (HR  =  0.62, 95% CI: 0.38 to 1.02 for dying from breast cancer with increasing HI) and tumor p53 status (HR  =  1.95, 95% CI: 0.93 to 4.1 for a p53 mutation carrier vs. non-carrier) with disease-specific survival, suggesting that these two variables are likely independent predictors of survival in larger studies.